Precision BioSciences, Inc.
DTIL
$6.69
-$0.67-9.10%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/4/2025
-
MarketBeat
11/4/2025
-
TipRanks Financial Blog
11/3/2025
-
GuruFocus
11/3/2025
-
GuruFocus
11/3/2025
-
GuruFocus
11/3/2025
-
The Fly
11/3/2025
-
Business Wire
11/3/2025
-
TipRanks Financial Blog
11/3/2025
-
TipRanks Financial Blog
11/1/2025
-
MarketBeat
10/31/2025
-
GuruFocus
10/31/2025
-
Business Wire
10/31/2025
-
Simply Wall St
10/27/2025
-
MarketBeat
10/26/2025
-
MarketBeat
10/16/2025
-
Zacks Investment Research
10/14/2025
-
Business Wire
10/9/2025
-
GuruFocus
10/9/2025
-
GuruFocus
10/9/2025
-
TipRanks Financial Blog
10/9/2025
-
The Fly
10/9/2025
-
Business Wire
10/9/2025
-
MarketBeat
10/7/2025
-
GuruFocus
10/7/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
919 314 5512
Address
302 East Pettigrew St.
Durham, NC 27701
Durham, NC 27701
Country
Year Founded
Business Description
Sector
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United...
more